Lupin Announces Health Canada approval of tiotropium bromide inhalation powder for treatment of COPD

11 July 2023 - Lupin announced that on 26 May 2023, its Canada subsidiary, Lupin Pharma Canada received approval from ...

Read more →

JAMP Pharma Group receives Health Canada approval for JAMP Sitagliptin, a new generic alternative for the treatment of type 2 diabetes

6 January 2022 - The JAMP Pharma Group is pleased to announce the Health Canada approval of JAMP Sitagliptin, a generic ...

Read more →

Sandoz Canada expands its generics portfolio with three new products

5 July 2022 - Generic medicines like these three products help make effective medicine more affordable and accessible for Canadians and ...

Read more →

Natco Pharma (Canada) announces the launch of Nat-Lenalidomide capsules, the first generic alternative to Revlimid

1 September 2021 - Nat-Lenalidomide expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to ...

Read more →

Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market

19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...

Read more →

Supporting greater availability of lower cost generic drugs for Canadians

4 April 2019 - Canadians want improved access to a wider range of safe and affordable medications.  ...

Read more →